Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients.
- 2025-02-07
- RCT · n = 90
- BMC gastroenterology 25(1)
- Qiyao Wei
- Jing Zhao
- PubMed: 39920583
- DOI: 10.1186/s12876-025-03600-z
- High evidence
- Clinical
TBIL decreased from 61.78 ± 4.94 µmol/L to 18.82 ± 2.93 µmol/L in the observation group and from 61.32 ± 4.93 µmol/L to 26.70 ± 4.44 µmol/L in the control group (P < 0.05).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes